Automated auditory brainstem response in neonatal hearing screening

Straaten, Hlm van

doi:10.1111/j.1651-2227.1999.tb01165.x

Cited by 44 publications

(10 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The AABR was considered a failed screen if the hearing level exceeded 30 dB NHL (decibel normal hearing level) in one or both ears according to the manufacturer's algorithm. The sensitivity and specificity of the ALGO hearing screeners are 100% and 97%–100%, respectively 4 20. The AABR was repeated prior to discharge for those infants who failed in one or both ears.…”

Section: Methodsmentioning

confidence: 99%

Antenatal factors modulate hearing screen failure risk in preterm infants

Leung

Cifra

Agthe

et al. 2015

Arch Dis Child Fetal Neonatal Ed

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 99%

Antenatal factors modulate hearing screen failure risk in preterm infants

Leung

Cifra

Agthe

et al. 2015

Arch Dis Child Fetal Neonatal Ed

View full text Add to dashboard Cite

show abstract

“…Abnormal auditory brainstem evoked response (ABR) considered impaired when the infant's ABR hearing levels exceeded 35 dB in at least one ear. 20 Long-term outcome as abnormal neurodevelopment or hearing were not included because they are beyond the scope of this review. The secondary outcome variables included the side effects of phototherapy, such as (1) hypothermia (body temperature <36.5°C), (2) hyperthermia (body temperature > 37.5°C), (3) skin rash or burns, (4) diarrhea, and (5) dehydration (weight loss >10% in term and >15% in preterm neonates).…”

Section: Methodsmentioning

confidence: 99%

Light-Emitting Diode (LED) Phototherapy versus Non-LED Phototherapy Devices for Hyperbilirubinemia in Neonates: A Systematic Review and Meta-analysis

2022

View full text Add to dashboard Cite

Objective: This review was conducted to evaluate the efficacy of light-emitting diode (LED) phototherapy as compared to the conventional phototherapy in neonates with unconjugated hyperbilirubinemia and their adverse effects. Study Design: We searched the following databases right from their inception till April, 2021: MEDLINE, EMBASE, Cochrane Library, and LILACS. Randomized clinical trials (RCTs) comparing the LED phototherapy with other light sources, which enrolled newborns (term and preterm) with unconjugated hyperbilirubinemia were included. Results: We included 21 articles in this review. The treatment with the LED light therapy had a lower failure rate as compared to the non-LED one (RR 0.60, 95% CI 0.39 to 0.94). The mean duration of phototherapy was significantly shorter in the group with the LED light source as compared to the one with the non-LED light source (mean difference (hours) −8.07, 95% CI −8.45 to −7.68), regardless of the type of non-LED units. However, the rate of bilirubin showed a comparable decline (mean difference (mg/dL/hour) 0.01, 95% CI −0.00, 0.03) in both the light sources, irrespective of irradiance or distance. No studies reported primary outcomes related to the neurotoxicity effects of hyperbilirubinemia in neonates. The LED light devices caused a significantly higher risk of hypothermia. Neonates were at a lower risk of developing hyperthermia and skin rash with the LED light therapy. Conclusion: Our findings provide support for the use of LED light source phototherapy due to its better clinical efficacy, which is evidenced by its shorter duration and lower rate of treatment failure, as compared to the non-LED light sources.

show abstract

“…Therefore, hearing screening is performed using AABR devices that record the V wave by providing an auditory stimulus (click, chirp, etc.) at the 35–40 dB nHL level [9] . AABR measurements offer general information about the peripheral auditory system, eighth cranial nerve, and auditory brainstem.…”

Section: Introductionmentioning

confidence: 95%